Aseptic insertion of central venous lines to reduce bacteraemia

Ferguson, Chantal S; D’Abrera, Victoria C; Van Gessel, Helen J; Jones, Dorothy

doi:10.5694/mja11.10775

Topics

To the Editor: We would like to congratulate the Central Line Associated Bacteraemia in NSW Intensive Care Units Collaborative for reducing central line-associated bacteraemia (CLAB), and showing that this reduction was associated with compliance with evidence-based aseptic central venous line (CVL) insertion, which included a patient bundle and a clinician bundle, as reported by Burrell and colleagues.1

1 Department of Health, Perth, WA.
2 Department of Health, Albany, WA.

Correspondence: Victoria.D’AbreraAThealth.wa.gov.au

1. Burrell AR, McLaws ML, Murgo M, et al. Aseptic insertion of central venous lines to reduce bacteraemia. The Central Line Associated Bacteraemia in NSW Intensive Care Units (CLAB ICU) Collaborative. Med J Aust 2011; 194: 583-587. <MJA full text>
2. Department of Health, Western Australia. Office of Safety and Quality in Healthcare. Safety and Quality Investment for Reform. A handbook for building a safer health care system. http://www.safetyandquality.health.wa.gov.au/docs/squire/SQuIReHandbook.pdf (accessed Sep 2011).
3. National Health and Medical Research Council. Australian guidelines for the prevention and control of infection in healthcare (2010). Canberra: NHMRC, 2010. http://www.nhmrc. gov.au/node/30290 (accessed Sep 2011).
4. O’Grady NP, Alexander M, Burns LA, et al. Healthcare Infection Control Practices Advisory Committee. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control 2011; 39 (4 Suppl 1): S1-S34.
5. Pratt RJ, Pellowe CM, Wilson JA, et al. epic2: National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect 2007; 65 Suppl 1: S1-S64.

Online responses are no longer available. Please refer to our instructions for authors page for more information.